ReviewBiomolecules2026

From ALL to Myeloid and NK Malignancies: Operationalizing "ASNS-Low" for L-Asparaginase Repurposing and Combination Therapy.

Toshiyuki KitohPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.